Is Routine COVID-19 Saliva Testing in Childcare an Effective Prevention Measure?
Weekly screenings for COVID-19 using at-home saliva tests were feasible and may mitigate outbreaks among children in childcare environments, according to new research by the Yale School of Nursing and Public Health.Source: Clinical Advisor
CDC internship affirms YSPH student’s commitment to public health research and policy
Yale School of Public Health (YSPH) second-year student Steph Tan, MPH ’23, found a perfect match for her interest in health policy and research this summer working as an intern in the Washington, D.C. office of the U.S. Centers for Disease Control and Prevention.
YSPH Research Scientist Anne Wyllie Discusses Success of SalivaDirect Testing Protocol
Yale School of Public Health Research Scientist Anne Wyllie, principal investigator for the SalivaDirect Initiative, recently discussed an upcoming conference, the success of SalivaDirect, and its potential future applications.
SalivaDirect Initiative hosts first annual conference on saliva-based testing
The SalivaDirect Initiative of the Yale School of Public Health (YSPH) will host its first annual conference on July 28-29, 2022 in Chicago, Illinois. Bringing together laboratory and industry professionals, researchers, and public health leaders, the agenda delves into the evolving role of saliva-based testing as a diagnostic solution for effective, efficient global emergency response efforts and improved public health, now and into the future.
Saliva-based open-source tests for COVID-19: How saliva sampling improves compliance, saves costs, and relieves the strained supply chain
A microbiologist at Yale University decided to test saliva samples for COVID-19 detection, and it resulted in a widely used, cost-effective, and accessible test for the publicSource: SelectScience
New partnership between CT, Yale to expand saliva-based COVID testing at 2 New Haven locations
A new partnership between the state Department of Public Health and the SalivaDirect Initiative of the Yale School of Public Health and Yale Pathology Labs will provide additional COVID-19 testing and lab capacity in the city, officials said Thursday.Source: The New Haven Register
Yale Pathology Labs, Yale School of Public Health Launch Public SalivaDirect™ Saliva PCR Testing Sites in New Haven
Yale Pathology Labs and the Yale School of Public Health have partnered to establish two COVID-19 mobile testing sites in New Haven that offer SalivaDirect™ Saliva PCR Testing to city residents with no pre-registration required.
Covid-19: Call for clarity around rapid antigen testing strategy
Asia Pacific Healthcare Group chief executive Anoop Singh has access to all forms of testing for his staff: the traditional nasopharyngeal swabs, saliva polymerase chain reaction (PCR) testing, and rapid antigen testing.Source: Stuff
Health & Veritas: The Saliva Test (Ep. 8)
On the Health & Veritas podcast, Yale physician-professors Howard Forman and Harlan Krumholz talk about the latest news and ideas in healthcare and seek out the truth amid the noise. In the latest episode, they are joined by Anne Wyllie, the Yale scientist who developed the SalivaDirect test for COVID-19, which was tested in the NBA’s 2020 “bubble” and is now available across the U.S. They discuss the development of the technology and its potential for enabling easier testing in a variety of communities.Source: Yale Insights
FDA authorizes SalivaDirect for pooled COVID-19 testing
SalivaDirect, a Yale-created protocol that allows for greater efficiency in COVID-19 testing, has received FDA emergency use authorization to be used for pooled COVID-19 virus testing of up to five individual samples at a time.Source: Yale Daily News